The French early arthritis registry
- PMID: 14969063
The French early arthritis registry
Abstract
This report is focused on two French multicenter cohorts of patients with early rheumatoid arthritis (RA). The first one is a community-based study which was started in 1993. It was mainly designed to identify prognostic factors of joint destruction, disability and remission in patients with early RA. The 3-year and 5-year results have been recently reported. Briefly, progression of joint damage was best predicted at baseline by radiographic scores, ESR, CRP, rheumatoid factor and DRB1*04 genes, and disability by disease activity including the HAQ score. Recently, the French Society of Rheumatology initiated a large national multicenter registry (800 patients), the "ESPOIR cohort study", that could serve as a database to allow investigations not only on diagnostic and prognostic markers, but also on etiologic, pathogenic and medico-economic factors among patients with early inflammatory arthritis who could later develop RA. The objectives, design and organization of this early arthritis registry are described.
Similar articles
-
Databases of patients with early rheumatoid arthritis in the USA.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S146-53. Clin Exp Rheumatol. 2003. PMID: 14969067 Review.
-
Early arthritis and rheumatoid arthritis in Germany.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S106-12. Clin Exp Rheumatol. 2003. PMID: 14969060 Review.
-
The Austrian Early Arthritis Registry.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S113-7. Clin Exp Rheumatol. 2003. PMID: 14969061 Review.
-
Early rheumatoid arthritis in Finland.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S133-7. Clin Exp Rheumatol. 2003. PMID: 14969065 Review.
-
Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S129-32. Clin Exp Rheumatol. 2003. PMID: 14969064 Review.
Cited by
-
The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.J Rheumatol. 2009 May;36(5):934-42. doi: 10.3899/jrheum.080762. Epub 2009 Mar 13. J Rheumatol. 2009. PMID: 19286850 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials
Miscellaneous